BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 28593402)

  • 1. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial gliomas in neurofibromatosis type 1.
    Listernick R; Charrow J; Gutmann DH
    Am J Med Genet; 1999 Mar; 89(1):38-44. PubMed ID: 10469435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome in children with gliomas of the anterior visual pathway.
    Tow SL; Chandela S; Miller NR; Avellino AM
    Pediatr Neurol; 2003 Apr; 28(4):262-70. PubMed ID: 12849878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
    Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
    Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special issues in the management of gliomas in children with neurofibromatosis 1.
    Pollack IF; Mulvihill JJ
    J Neurooncol; 1996; 28(2-3):257-68. PubMed ID: 8832467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromatosis type I (NF1): peculiarities and complications].
    Pascual-Castroviejo I
    Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
    Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications of neurofibromatosis type 1 in adulthood.
    Créange A; Zeller J; Rostaing-Rigattieri S; Brugières P; Degos JD; Revuz J; Wolkenstein P
    Brain; 1999 Mar; 122 ( Pt 3)():473-81. PubMed ID: 10094256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
    Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T; Pfister SM; Rood B; Rodriguez FJ; Tabori U; Ramaswamy V; Zhu Y; Fangusaro J; Johnston SA; Gutmann DH
    Neuro Oncol; 2020 Jun; 22(6):773-784. PubMed ID: 32055852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
    Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications.
    Shamji MF; Benoit BG
    Neurosurg Focus; 2007; 23(5):E3. PubMed ID: 18004965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-optic glioma in adults and children with neurofibromatosis 1.
    Sellmer L; Farschtschi S; Marangoni M; Heran MK; Birch P; Wenzel R; Friedman JM; Mautner VF
    Orphanet J Rare Dis; 2017 Feb; 12(1):34. PubMed ID: 28202035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
    Farmer JP; Khan S; Khan A; Ortenberg J; Freeman C; O'Gorman AM; Montes J
    Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.